Per Falk

Board Member. Dr. Falk received both his M.D and his PhD (Hydrolysis of Glycosphingolipids) from University of Gothenburg, Sweden. Dr Falk was a Post-doctoral fellow at the Department of Molecular Biology, and Washington University School of Medicine, St. Louis, MO. Member of the Medical Microbial Ecology, and Department of Medicine, The Karolinska Institute. Vice President of Development, Novo Nordisk Tokyo, Director of Molecular Biology, and Gastrointestinal Pharmacology AstraZeneca Sweden, Associate Director, Molecular Biology, Astra Hassle AB, Sweden, Lecturer at the Karolinska Institute, Gothenburg University and Umea University.